| 1/7 | US=94 / Biol/Mol Matthews DJ, Gerritsen ME. Cell cycle control. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 327-90. ISBN 978-0-470-22965-1. CICLO CELULAR; QUINASES CICLICAS DEPENDENTES (CDK); CDK4; CDK6; CDK2; CDK3; CDK1; CDK10; CCRK; CDCH; PRODUCAO DE MRNA; CDK7; CDK8; CDK9; CDK11; CDK12; CDK13; CDK5; QUINASE CICLINA G-ASSOCIADOS (GAK); QUINASES MITOTICAS; QUINASE POLO-LIKE (PLK); AURORA-QUINASE; ATAXIA-TELANGIECTASIA MUTADO (ATM); ATAXIA TELANGIECTASIA E PROTEINA RAD3 RELACIONADOS (ATR); CHK1; CHK2; MAPKAPK2 |
| 2/7 | US=94 / Biol/Mol Matthews DJ, Gerritsen ME. Structural biochemistry of kinase inhibitors. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 391-434. ISBN 978-0-470-22965-1. INIBIDORES DE QUINASES; BIOQUIMICA ESTRUTURAL; ESTRATEGIAS INIBIDORAS; ARQUITETURA ATP; INIBIDORES DE CHK1; INIBIDORES DE CDK2; INIBIDORES DA FAMILIA SRC; INIBIDORES DO RECEPTOR EGF; CONFORMACAO INATIVA; INIBICAO NAO-COMPETITIVA |
| 3/7 | US=58 / Câncer Hurley PJ, Bunz F. Distinct pathways involved in s-phase checkpoint control. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 27-36. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CONTROLO S-CHECKPOINT; INTRA-S-FASE CHECKPOIN; CHECKPOIN REPLICACAO; S-M CHECKPOINT; ATR; CHK1; CHK2; REPLICACAO DO DNA |
| 4/7 | US=58 / Câncer Krämer A. Centrosomes in checkpoint responses. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 53-67. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CENTROSSOMAS NAS RESPOSTAS CHECKPOINT; CENTROSSOMA; DANOS NO DNA; CHECK-POINT; CHK1; PERICENTRIN; MICROCEFALINA; CDC25; SINDROME SECKEL; MICROCEFALIA; AMPLIFICACAO CENTROSSOMA; CATASTROFE MITOTICA |
| 5/7 | US=58 / Câncer Nakanishi M. Chromatin modifications and orchestration of checkpoint response in cancer. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 83-93. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. MODIFICACOES DE CROMATINA; ORQUESTRACAO DE RESPOSTA; CONTROLE EM CANCER; CHK1; CHK2; P53; REPLICACAO DO DNA |
| 6/7 | US=58 / Câncer Eastman A. The importance of p53 signaling in the response of cells to checkpoint inhibitors. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 189-98. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; PARADA DO CICLO CELULAR; P53; P21; CICLINA B; CHK1 INIBIDORES; UCN-01; INIBIDORES DA TOPOISOMERASE II; ANALOGOS DE NUCLEOSIDOS |
| 7/7 | US=58 / Câncer Zhang H, Xiao Z, Sowin T. ChK1 and ChK2 as checkpoint targets. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 245-59. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CHK1; CHK2; INIBIDORES; PARADA DO CICLO CELULAR; REVOGACAO DA RESPOSTA CHECKPOINT; CHEMOPROTECTION; BIOMARCADORES PREDITIVOS |